ABCB11 and hepatocellular carcinoma: If a reduction in HCC risk is found, this may suggest that at least part of the HCC risk in these patients could also relate to bile acid toxicity, perhaps in a similar way to that described in Section 4 for PFIC 2 patients with ABCB11 changes.